[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"endobronchial-ultrasound---transbronchial-needle-aspiration\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:endobronchial-ultrasound---transbronchial-needle-aspiration":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100645186","consent-understanding-and-propofol-requirement-during-endobronchial-ultrasound-100645186",false,"NCT07677982","Consent Understanding and Propofol Requirement During Endobronchial Ultrasound","Association of Preoperative Consent Understanding With Propofol Requirement During Endobronchial Ultrasound: A Prospective Observational Study","Inclusion Criteria:\n\n* Age 18 years or older\n* Scheduled for elective endobronchial ultrasound\n* ASA physical status I to III\n* Ability to read and understand Turkish\n* Provision of written informed consent for study participation\n\nExclusion Criteria:\n\n* Active psychiatric disease that may affect the informed consent process, anxiety assessment, or communication\n* Cognitive impairment, including dementia or delirium\n* Contraindication or known allergy to propofol, midazolam, or remifentanil\n* Emergency EBUS procedure\n* Regular anxiolytic or sedative drug use within the last month\n* Illiteracy\n* Turkish language barrier\n* Advanced organ failure or decompensated systemic disease that may significantly affect sedative drug response, hemodynamic stability, communication, or consent assessment","ALL","18 Years",{"count":19,"type":20},75,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn whether a participant's understanding of the informed consent information is related to the amount of propofol needed during endobronchial ultrasound (EBUS). EBUS is a procedure that uses a thin camera and ultrasound to look at lymph nodes and other areas inside the chest. Propofol is a sedative medicine used to help participants stay comfortable during the procedure.\n\nBefore EBUS, all participants will receive the usual information about the procedure as part of routine care. After this routine consent process, participants will answer short questions about what they understood. They will also answer questions about their anxiety before the procedure. The study will not change the usual consent process, sedation plan, or medical care.\n\nDuring EBUS, participants will receive usual sedation and monitoring according to routine clinical practice. The research team will record how much sedative medicine is used, whether extra sedation is needed, whether any important clinical events occur, and how participants recover after sedation. The main question is whether participants who understand the consent information better need less propofol during EBUS.",[24,25,26],"ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION","Procedural Sedation and Analgesia","Informed Consent",[28,29,30,31,32,33],"EBUS-TBNA","Informed consent understanding","Procedural sedation","Preoperative anxiety","Sedative requirement","Propofol consumption","NOT_YET_RECRUITING","2026-06-30",{"date":37,"type":38},"2026-07-01","ACTUAL",{"date":37,"type":20},{"date":41,"type":20},"2027-07-01",{"name":43,"class":44},"Uludag University","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":45},"100638504","the-role-of-ultrasonographic-tracheal-measurements-in-predicting-hypoxemia-during-endobronchial-ultrasound-guided-transbronchial-needle-aspiration-100638504","NCT07587736","The Role of Ultrasonographic Tracheal Measurements in Predicting Hypoxemia During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration","The Role of Ultrasonographic Tracheal Measurements in Predicting Hypoxemia During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Prospective Observational Study","Inclusion Criteria:\n\n* Patients scheduled for elective EBUS-TBNA\n* Patients who provide written informed consent\n* Patients with ASA physical status I-III\n* Patients aged ≥18 years\n\nExclusion Criteria:\n\n* Tracheal stenosis or significant airway obstruction\n* History of tracheostomy\n* Use of home oxygen therapy\n* Pre-procedural SpO₂ \\\u003C 90% on room air\n* History of prior thoracic surgery\n* Diagnosis of congestive heart failure\n* Presence of pleural effusion\n* FEV1 \\\u003C 40%\n* COPD patients classified as GOLD stage 3-4\n* Restrictive lung disease (FVC \\\u003C 50%)\n* Advanced pulmonary hypertension\n* History of surgery affecting neck anatomy\n* Tracheal deviation due to large thyroid or mediastinal mass\n* ASA physical status IV\n* Pregnancy\n* EBUS performed under general anesthesia (with endotracheal intubation or laryngeal mask airway)\n* Hemodynamic instability",{"count":54,"type":20},300,"Bronchoscopic procedures performed under endobronchial ultrasound (EBUS) guidance are widely used minimally invasive diagnostic methods for the evaluation of mediastinal lymph nodes. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) is an indicated procedure for the diagnosis, staging, and histopathological characterization of primary or metastatic tumors. The procedure is generally performed under moderate or deep sedation to enhance patient comfort and optimize procedural success. Deep sedation has been shown to be a safe and effective approach in terms of respiratory complications in both younger and elderly patients.\n\nHowever, hypoxemia may develop during EBUS procedures due to mechanisms such as mechanical airway obstruction, sedation-related ventilatory depression, and ventilation-perfusion mismatch. A decrease in oxygen saturation is frequently observed during bronchoscopic procedures, with reported rates of up to 94%. Studies have also reported a hypoxemia rate of approximately 25% during EBUS, even with the use of a nasopharyngeal oxygen cannula. Therefore, maintaining adequate oxygenation throughout the procedure is of critical importance. In patients receiving sedation under spontaneous respiration, oxygen support is typically provided via low-flow systems such as nasal cannulae, which can generally deliver flows of up to 15 L\u002Fmin.\n\nIt has been reported that a fiberoptic bronchoscope occupies approximately 10% of the tracheal cross-sectional area and about 15% at the level of the cricoid ring, leading to partial obstruction. EBUS endoscopes have a larger outer diameter and, in addition, may exert more pronounced negative effects on respiratory mechanics due to the balloon mechanism used. The outer diameter of EBUS bronchoscopes typically ranges between 6.2 and 6.7 mm, mechanically occupying a significant portion of the tracheal lumen. This may restrict tracheal airflow, leading to partial obstruction and consequently predisposing to hypoxemia. Therefore, identifying objective anatomical predictors that can predict the development of hypoxemia is of clinical importance. However, to the best of our knowledge, no study in the literature has statistically investigated the relationship between tracheal measurements and hypoxemia occurring during EBUS.\n\nIn this study, the investigators aim to investigate the relationship between pre-procedural tracheal diameter measured by ultrasonography (USG) and the EBUS outer diameter\u002Ftracheal diameter ratio (airway occupancy ratio) with the development of hypoxemia during the procedure in patients undergoing EBUS-TBNA. Additionally, it is aimed to determine the optimal tracheal diameter cutoff value that may predict the development of hypoxemia.\n\nStudy Design and Patient Population This study will be conducted in accordance with the Declaration of Helsinki and will be carried out at SBÜ Ankara Atatürk Sanatoryum Training and Research Hospital after obtaining approval from the institutional ethics committee. The study is planned as a prospective observational cohort study. Adult patients scheduled to undergo EBUS-TBNA will be included.\n\nThe following parameters will be recorded:\n\n* Age\n* Sex\n* Body mass index (BMI)\n* FEV1 value\n* Baseline SpO₂\n* Lowest recorded SpO₂\n* Systolic\u002Fdiastolic\u002Fmean arterial blood pressure and heart rate measured at 10-minute intervals during the procedure\n* Sedative drug doses\n* Procedure duration\n* Tracheal diameter measured by ultrasonography (USG)\n* Airway occupancy ratio (EBUS outer diameter \u002F narrowest tracheal diameter measured by USG)\n* Duration and total number of hypoxic episodes during the procedure\n* Requirement for airway interventions (jaw thrust, mask ventilation, intubation, etc.)\n* Whether nasal oxygen flow was increased in case of hypoxemia, and if so, by how many L\u002Fmin\n* Presence of cough, hiccups, secretions requiring aspiration, bronchospasm, and procedure-related bleeding\n* Whether the procedure was interrupted",[24,57,58],"Hypoxemia","Trachea",[60,61,62,63],"ENDOBRONCHIAL ULTRASOUND","TRANSBRONCHIAL NEEDLE ASPIRATION","TRACHEAL DIAMETER","HYPOXEMİA","2026-05-11",{"date":66,"type":38},"2026-05-14",{"date":68,"type":20},"2026-05-20",{"date":70,"type":20},"2027-05-01",{"name":72,"class":73},"Ankara Ataturk Sanatorium Training and Research Hospital","OTHER_GOV"]